A systematic review reported EoE in up to 2.7% of patients undergoing OIT for IgE‐mediated food allergy (although the review is based on incomplete datasets, because most trials of OIT have not reported the presence or absence of EoE as a longer‐term adverse event) 94. This evidence concerns the gene IGHE and food allergy.